3rd Annual Innovative Pharma Pricing & Market Access Strategies Summit
10-11

April 2019

Germany

Berlin

About

We would like to welcome you to the 3rd Annual Innovative Pharma Pricing & Market Access Strategies Summit on April 10th-11th, 2019! This event provides participants and industry leaders with an environment that allows for discussions regarding developments in Pharma Pricing & Market Access to take place. This Summit will also provide attendees with a broad overview of current market trends and what the future has in store for this industry. This Summit will focus on the latest developments and innovations in Pharma Pricing & Market Access in...

We would like to welcome you to the 3rd Annual Innovative Pharma Pricing & Market Access Strategies Summit on April 10th-11th, 2019! This event provides participants and industry leaders with an environment that allows for discussions regarding developments in Pharma Pricing & Market Access to take place. This Summit will also provide attendees with a broad overview of current market trends and what the future has in store for this industry. This Summit will focus on the latest developments and innovations in Pharma Pricing & Market Access including market access trends, evidence-based pricing, pricing and payer strategies, rare diseases, and innovations in therapeutics. Attendees will have the opportunity to learn from industry leaders and experts and network with them to find practical solutions to industry problems and explore future developments in Pharma Pricing & Market Access.

more info
Who Should Attend

CEOs / Presidents / MDs, CCOs/CMOs/CDOs, Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:

  • Business Development
  • Sales
  • Market Access
  • Marketing Intelligence
  • Product Launch
  • Pricing Policy
  • Health Technology Assessment
  • Health Informatics
  • Value Strategy
  • Tendering
  • Marketing
  • Pricing
  • Medical Director
  • Drug Pricing
  • Health Economics
  • Product Reimbursement
  • Real World Evidence
  • Data Sciences
  • P&MA
Key Practical Learning Points of the Summit

Pharma strategy, pricing, and commercial excellence
Developing successful pricing & negotiation strategies
Global reimbursement issues and stakeholder requirements
Market access trends
Collaborating to increase value and access
Reimbursement of pharmaceuticals in European countries: finding your way to the market
Real-world evidence (RWE): driving a new drug development paradigm in oncology
Cell and gene therapies: achieving market access across the globe
Patient access to medicines for rare diseases in Europe vs US countries
Value Frameworks proposed in the United States
Speakers
Oliver Leatham, UK

Vice President, Head of Value & Access

Analytica Laser, a Certara company

Michele Siccardi, CH

Head of Program Realisation, Patient Value & Access

Takeda

Jörg Mahlich, JP

Health Economist

Janssen

Michael Lees, CH

Head of Value, Evidence & Portfolio Strategy (EUCAN)

Takeda

Friedrich-Wilhelm Leverkus, DE

Director of Health Technology Assessment & Outcomes Research Health & Value Germany

Pfizer Deutschland GmbH

Aurelio Arias, UK

Senior Thought Leadership Consultant

IQVIA

Jolanda Koenders, NE

Jolanda Koenders, NE

Novartis

Axel Boehnke, DE

Director of Market Access

MorphoSys AG

Massimo Berzigotti, UK

Vice President

Stratence Partners

Charles-Etienne de Cidrac, FR

Health Director

AXA

Sehram Zayer, TR

Managing Director

Merck Group Turkey

Patti Jewell, US

Senior Director, Public Affairs for Oncology

Pfizer

Dr. Martin Strandberg-Larsen, DK

Vice President, Market Access & Pricing

AstraZeneca A/S

Annual

Events

Sponsors and Partners

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

"